Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

FDA approves Biotronik ICD systems for use with MRI scans

The FDA approved the ProMRI implantable cardioverter defibrillator (ICD) systems for use with full-body MRI scans on Dec. 22.

FDA approves LifeVest wearable cardioverter defibrillator for children

The FDA approved the LifeVest wearable cardioverter defibrillator (Zoll Lifecor Corp.) on Dec. 17 to treat some children who are at risk for sudden cardiac arrest. The device was approved in 2001 for adults who were at least 18 years old.

ACC launches data registry for left atrial appendage occlusion devices

The American College of Cardiology (ACC) launched a registry on Dec. 16 to track data on left atrial appendage occlusion (LAAO) devices.

Thumbnail

ACC, SCAI, HRS release consensus statement on left atrial appendage occlusion requirements

Three leading cardiology societies released a consensus statement on Dec. 10 regarding criteria institutions and operators should follow for left atrial appendage occlusion.

Thumbnail

Society of Thoracic Surgeons releases CABG guidelines

Clinicians performing CABG should use arteries from the chest and forearm instead of veins from the leg in certain patients, according to guidelines from the Society of Thoracic Surgeons (STS).

Thumbnail

Boston Scientific voluntarily recalls the Chariot guiding sheath

Boston Scientific announced on Dec. 9 that it had voluntarily recalled its Chariot guiding sheath after receiving 14 complaints of shaft separation. The FDA classified it as a Class 1 recall, which is the most serious type of recall.

Renal dysfunction before CABG increases costs and healthcare utilization

A database analysis found that patients undergoing CABG had higher costs and hospital resource utilization if they had renal dysfunction before undergoing surgery.

Predicting 30-day readmissions for heart failure patients remains challenging

A model developed to predict 30-day readmissions for heart failure found that having patients self-report their socioeconomic, health status and psychosocial characteristics did not improve the researchers’ ability to determine the readmissions risk.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.